KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Shares Outstanding (2017 - 2025)

Guardant Health (GH) has disclosed Shares Outstanding for 9 consecutive years, with $130.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 5.36% to $130.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $130.6 million through Dec 2025, up 5.36% year-over-year, with the annual reading at $130.6 million for FY2025, 5.36% up from the prior year.
  • Shares Outstanding hit $130.6 million in Q4 2025 for Guardant Health, up from $126.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $130.6 million in Q4 2025 to a low of $101.1 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $113.6 million across 5 years, with a median of $117.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding: increased 0.78% in 2022 and later rose 18.58% in 2024.
  • Year by year, Shares Outstanding stood at $101.8 million in 2021, then grew by 0.84% to $102.6 million in 2022, then grew by 18.53% to $121.6 million in 2023, then rose by 1.94% to $124.0 million in 2024, then increased by 5.36% to $130.6 million in 2025.
  • Business Quant data shows Shares Outstanding for GH at $130.6 million in Q4 2025, $126.0 million in Q3 2025, and $124.5 million in Q2 2025.